Cargando…

P1002: PROTEOMIC SCREENING IDENTIFIES MEGAKARYOCYTE DERIVED PF4/CXCL4 AS A CRITICAL DRIVER OF MYELOFIBROSIS

Detalles Bibliográficos
Autores principales:	Malara, Alessandro, Abbonante, Vittorio, Rossella Calledda, Francesca, Capitanio, Daniele, Cattaneo, Daniele, Iurlo, Alessandra, Gelfi, Cecilia, Balduini, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431582/ http://dx.doi.org/10.1097/01.HS9.0000970912.44096.3f

Ejemplares similares

P989: NEWLY IDENTIFIED ROLES FOR PIEZO1 MECHANOSENSOR IN CONTROLLING NORMAL MEGAKARYOCYTE DEVELOPMENT AND IN PRIMARY MYELOFIBROSIS
por: Abbonante, Vittorio, et al.
Publicado: (2023)

EDA fibronectin–TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosis
por: Malara, Alessandro, et al.
Publicado: (2019)

Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver
por: Malara, Alessandro, et al.
Publicado: (2018)

Treatment of Myelofibrosis: Old and New Strategies
por: Iurlo, Alessandra, et al.
Publicado: (2017)

Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis
por: Campanelli, Rita, et al.
Publicado: (2016)

Sub-Cellular Localization of Metalloproteinases in Megakaryocytes
por: Malara, Alessandro, et al.
Publicado: (2018)

Trend of circulating CD34(+) cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatment
por: Iurlo, Alessandra, et al.
Publicado: (2022)

Outside-In Signalling Generated by a Constitutively Activated Integrin α(IIb)β(3) Impairs Proplatelet Formation in Human Megakaryocytes
por: Bury, Loredana, et al.
Publicado: (2012)

Editorial: Megakaryocytes as regulators of tumor microenvironments
por: Migliaccio, Anna Rita, et al.
Publicado: (2022)

Is it primary myelofibrosis or chronic megakaryocytic leukemia?
por: Lichtman, Marshall A.
Publicado: (2022)

High Doses of Romiplostim Induce Proliferation and Reduce Proplatelet Formation by Human Megakaryocytes
por: Currao, Manuela, et al.
Publicado: (2013)

iPSC diversity: A key for better use and improved targeting
por: Abbonante, Vittorio, et al.
Publicado: (2021)

An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review
por: Orofino, Nicola, et al.
Publicado: (2017)

Circulating megakaryocyte in primary myelofibrosis: an uncommon finding in a myelofibrosis blood smear
por: Cantó, Pedro Asensi, et al.
Publicado: (2021)

Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression
por: Malara, Alessandro, et al.
Publicado: (2022)

In Vitro Megakaryocyte Differentiation and Proplatelet Formation in Ph-Negative Classical Myeloproliferative Neoplasms: Distinct Patterns in the Different Clinical Phenotypes
por: Balduini, Alessandra, et al.
Publicado: (2011)

Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients
por: Tefferi, Ayalew, et al.
Publicado: (2018)

Effect of Interferon-γ on the Basal and the TNFα-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement Or the BRAF V600e Mutation
por: Rotondi, Mario, et al.
Publicado: (2016)

Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis
por: Cattaneo, Daniele, et al.
Publicado: (2022)

Megakaryocytes regulate hematopoietic stem cell quiescence via Cxcl4 secretion
por: Bruns, Ingmar, et al.
Publicado: (2014)

Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors
por: Cattaneo, Daniele, et al.
Publicado: (2021)

VEGFA rs3025039 is associated with phenotype severity of myelofibrosis‐type megakaryocyte dysplasia
por: Barosi, Giovanni, et al.
Publicado: (2023)

A Novel Megakaryocyte Subpopulation Poised to Exert the Function of HSC Niche as Possible Driver of Myelofibrosis
por: Migliaccio, Anna Rita
Publicado: (2021)

2508: The role of platelet factor-4 (PF4 or CXCL4) in B cell differentiation
por: Blick, Sara, et al.
Publicado: (2018)

Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis
por: Zingariello, Maria, et al.
Publicado: (2020)

Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options
por: Iurlo, Alessandra, et al.
Publicado: (2019)

Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis
por: Varricchio, Lilian, et al.
Publicado: (2022)

Constitutive STAT5 phosphorylation in CD34(+) cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity
por: Abbà, Carlotta, et al.
Publicado: (2019)

100-year-old Haematologica images: the origin of megakaryocytes
por: Balduini, Carlo L.
Publicado: (2020)

Pathophysiological Significance of Store-Operated Calcium Entry in Megakaryocyte Function: Opening New Paths for Understanding the Role of Calcium in Thrombopoiesis
por: Di Buduo, Christian A., et al.
Publicado: (2016)

Reduced CXCL4/PF4 expression as a driver of increased human hematopoietic stem and progenitor cell proliferation in polycythemia vera
por: Meier-Abt, Fabienne, et al.
Publicado: (2021)

Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives
por: Barosi, Giovanni, et al.
Publicado: (2023)

P1018: TREND OF CIRCULATING CD34+ CELLS IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
por: Cattaneo, D., et al.
Publicado: (2022)

Platelet factor 4 (CXCL4/PF4) upregulates matrix metalloproteinase-2 (MMP-2) in gingival fibroblasts
por: Le, Hoa T., et al.
Publicado: (2022)

Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients
por: Di Buduo, Christian A., et al.
Publicado: (2016)

New Perspectives on Polycythemia Vera: From Diagnosis to Therapy
por: Iurlo, Alessandra, et al.
Publicado: (2020)

Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge
por: Iurlo, Alessandra, et al.
Publicado: (2021)

PD‐L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
por: Lee, Sze‐Hwei, et al.
Publicado: (2021)

Pleomorphic circulating megakaryocytes in a case of CALR positive primary myelofibrosis in leukemic transformation
por: Moshref Razavi, Habib
Publicado: (2021)

Corrigendum: Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients
por: Di Buduo, Christian A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6tki6u079esv1iunidfljsp1d4